Stem cell therapies are being used increasingly to help treat diseases such as cancer, heart attacks, diabetes and incontinence. Currently, progress in clinical therapy using stem cells is occurring rapidly outside the U.S. Stematix, Inc. is a regenerative medicine technology and solutions provider positioned to accelerate safe and effective global use of stem cell therapies. Stematix believes that there is a need to fast-track stem cell therapies because of increasing demands on global healthcare systems to find more cost-effective treatments that can be used for rapidly growing populations. We believe this need can be met through the facilitation and establishment of public-private therapy clinic partnerships. Stematix is focusing its mission on regions of the world where partnerships with local entities and regulatory bodies can lead to such fast-track establishment of stem cell treatment meeting world standards of care. Stematix provides a unique comprehensive approach and commercial solutions to accelerate providing therapy on a larger scale:
Integrated RediStem™ solutions
Umbilical cord products (for research markets), storage and therapy